Romain Marignier
Faculté De Médecine Lyon Est
Lyon, France
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 253 publications
Treatment Discontinuation in MOGAD-One Size Does Not Fit All-Reply.
Journal: JAMA neurology
Published: August 31, 2026
De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD.
Journal: Neurology
Published: August 26, 2026
Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 11, 2026
Borrelia miyamotoi meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 04, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.
Journal: Neurology
Published: May 22, 2026
French guidelines for the diagnosis and management of primary central nervous system vasculitis.
Journal: La Revue de medecine interne
Published: May 06, 2026
External validation of KFLC index threshold for multiple sclerosis diagnosis in a French cohort.
Journal: Journal of neurology
Published: April 28, 2026
Early corticosteroids predict visual whereas MRI lesion extent predicts retinal atrophy outcomes in MOG antibody-associated optic neuritis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: April 15, 2026
French guidelines for the diagnosis and management of neuromyelitis optica spectrum disorder.
Journal: Revue neurologique
Published: April 10, 2026
Neuromyelitis Optica Spectrum Disorder.
Journal: Continuum (Minneapolis, Minn.)
Published: April 02, 2026
Last Updated: 09/26/2026